Finally, in our previous study, we were able to demonstrate an intricate crosstalk between patient-derived CAFs and lung cancer cells, in which mutant p53 induces the secretion of a factor from the neighboring cells and modulates the response to this factor in the cancer cells (Madar et al., 2013). This evidence concerns the gene TP53 and cancer.